ASTHMA-Educator Mobile Application Manage Asthma

Not Applicable

Completed

• Conditions: Asthma
• Interventions: Other: ASTHMA-Educator mobile application

• Registration Number: NCT03518879
• Lead Sponsor: Montefiore Medical Center

Brief Summary

Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore.

Detailed Description

Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use through 2 phases: 1) Phase 1 = process outcomes evaluation with 30 patients); and 2) Phase 2 (longitudinal clinical evaluation with 40 patients receiving the intervention at baseline, 2 months, 4 months, and 6 months). The study's primary outcome is asthma control.

Study Timeline

• Study Start: 2015-03
• Study First Submitted: 2018-04-13
• Study First Submitted QC: 2018-04-25
• Study First Posted: 2018-05-08
• Primary Completion: 2021-07-01
• Study Completion: 2021-07-01
• Status Verified: 2023-06
• Last Update Submitted: 2023-06-06
• Last Update Posted: 2023-06-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Adults (>18 years) with: (a) severe asthma (i.e. at least one asthma-related ED visit and/or hospitalization in the previous year); (b) access to a smartphone with short message service (SMS) capability; (c) English speaking; (d) able to give informed consent.

Exclusion Criteria

(a) use of oral corticosteroids in the 2 weeks prior to the baseline visit; (b) pregnancy; (c) severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol; and (d) patients that previously received the ASTHMAXcel application.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
ASTHMA-Educator arm	ASTHMA-Educator mobile application	The ASTHMA-Educator mobile application for patient-centered asthma education. The application is administered via on-site iPad (tablet).

Primary Outcome Measures

Name	Time	Method
Change from baseline asthma control to 2, 4, and 6 months	Baseline, 2 months, 4 months, 6 months	Asthma symptom burden as measured by the Asthma Control Test

Secondary Outcome Measures

Name	Time	Method
Change from baseline asthma knowledge to immediately post-intervention, 2 months, 4 months, and 6 months	Baseline, immediately post-intervention, 2 months, 4 months, 6 months	Asthma knowledge as measured by the validated Asthma Knowledge Questionnaire
Patient satisfaction measured by the Client Satisfaction Questionnaire-8	Immediately post-intervention at the baseline visit, 2 months, 4 months, 6 months	Patient satisfaction measured by the Client Satisfaction Questionnaire-8
Time spent in using the mobile application	Immediately post-intervention at the baseline visit	Time spent in using the mobile application
Asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)	Baseline, 2 months, 4 months, 6 months	Patients' asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
Asthma hospitalizations	Baseline, 2 months, 4 months, 6 months	Asthma hospitalizations
Asthma emergency department visits	Baseline, 2 months, 4 months, 6 months	Asthma emergency department visits
Asthma-related steroid courses	Baseline, 2 months, 4 months, 6 months	Asthma-related steroid courses

Trial Locations

Locations (1)

Montefiore Medical Center; 🇺🇸 Bronx, New York, United States